Johanna M. Gorol

Doctoral Researcher

Doctoral Researcher at the Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy

Johanna Gorol holds a Master’s degree in Molecular Medicine from Goethe University Frankfurt and is currently a PhD candidate at Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy. Her research focuses on improving T-cell-based tumor therapies by modulating the T cell phenotype. In this context, she investigates the impact of urolithin A supplementation on T cells in healthy adults and tumor patients, and its potential beneficial effects on cell therapy strategies.